GB201415094D0 - GPCR receptor binding domain and uses thereof - Google Patents

GPCR receptor binding domain and uses thereof

Info

Publication number
GB201415094D0
GB201415094D0 GBGB1415094.0A GB201415094A GB201415094D0 GB 201415094 D0 GB201415094 D0 GB 201415094D0 GB 201415094 A GB201415094 A GB 201415094A GB 201415094 D0 GB201415094 D0 GB 201415094D0
Authority
GB
United Kingdom
Prior art keywords
binding domain
receptor binding
gpcr receptor
gpcr
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1415094.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heptares Therapeutics Ltd
Original Assignee
Heptares Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heptares Therapeutics Ltd filed Critical Heptares Therapeutics Ltd
Priority to GBGB1415094.0A priority Critical patent/GB201415094D0/en
Publication of GB201415094D0 publication Critical patent/GB201415094D0/en
Priority to PCT/GB2015/052455 priority patent/WO2016030675A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
GBGB1415094.0A 2014-08-26 2014-08-26 GPCR receptor binding domain and uses thereof Ceased GB201415094D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1415094.0A GB201415094D0 (en) 2014-08-26 2014-08-26 GPCR receptor binding domain and uses thereof
PCT/GB2015/052455 WO2016030675A1 (en) 2014-08-26 2015-08-26 Gpcr receptor binding domain and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1415094.0A GB201415094D0 (en) 2014-08-26 2014-08-26 GPCR receptor binding domain and uses thereof

Publications (1)

Publication Number Publication Date
GB201415094D0 true GB201415094D0 (en) 2014-10-08

Family

ID=51727055

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1415094.0A Ceased GB201415094D0 (en) 2014-08-26 2014-08-26 GPCR receptor binding domain and uses thereof

Country Status (2)

Country Link
GB (1) GB201415094D0 (en)
WO (1) WO2016030675A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022188817A1 (en) * 2021-03-09 2022-09-15 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric gcgr genes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008004223A2 (en) 2006-07-03 2008-01-10 Se-Cure Pharmaceuticals Ltd. Compounds and methods for the treatment of menopause and bone related disorders
GB0724860D0 (en) 2007-12-20 2008-01-30 Heptares Therapeutics Ltd Screening
DE08718604T1 (en) 2008-03-05 2009-12-24 Medical Research Council crystal structure
EP2742066B1 (en) * 2011-08-10 2017-12-27 Heptares Therapeutics Limited Stable proteins
WO2013059531A1 (en) * 2011-10-20 2013-04-25 Genentech, Inc. Anti-gcgr antibodies and uses thereof

Also Published As

Publication number Publication date
WO2016030675A1 (en) 2016-03-03

Similar Documents

Publication Publication Date Title
HK1247199A1 (en) Estrogen receptor modulators and uses thereof
HK1257751A1 (en) Farnesoid x receptor agonists and uses thereof
HK1255067A1 (en) Anti-c10orf54 antibodies and uses thereof
HK1243440A1 (en) Anti-interleukin-33 antibodies and uses thereof
IL247407A0 (en) Anti-egfrviii antibodies and uses thereof
IL249373A0 (en) Formulated receptor polypeptides and related methods
HUE051919T2 (en) Cd3 binding domain
PL3152226T3 (en) Modified cyclopentapeptides and uses thereof
SG11201609490QA (en) Polymer-flavonoid conjugate and uses thereof
IL251001A0 (en) Anti-il-25 antibodies and uses thereof
HK1258886A1 (en) T-cell receptor and uses thereof
PL3347376T3 (en) Novel igfr-like receptor and uses thereof
HK1253294A1 (en) Opioid receptor modulators and use thereof
GB201413311D0 (en) Book
GB201415094D0 (en) GPCR receptor binding domain and uses thereof
HK1215418A1 (en) Loose-left folder device
PT3092081T (en) Application device

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)